Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the <scp>TOPICOP</scp> score

Stalder, J.‐F.; Aubert, H.; Anthoine, Emmanuelle; Futamura, Masaki; Marcoux, Danielle; Morren, Marie; Trzeciak, Magdalena; Szalai, Zsuzsanna; Veres, Klára; Deleuran, Mette; Vestergaard, Christian; Boralévi, F.; Chu, Chia-Yu; Raeve, Linda De; Svensson, Åke; Fölster‐Holst, Regina; Buchner, Matthias; Takaoka, Roberto; Aoki, Valéria; Chernyshov, Pavel V; Chernyshova, Liudmyla; Murrell, Dédée F.; Zhao, Cathy; McKinster, Carola Durán; Kobyletzky, L. Von; Eichenfield, Lawrence F.; Totri, Christine R.; Lio, Peter A.; Sénéschal, Julien; Moret, L.; Barbarot, S.

doi:10.1111/all.13189

Cited by 65 publications

(72 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Another limitation is that this Dutch translation of the Topicop is not validated. However, this does not seem to have influenced our findings since the mean Topicop sum score of parents in the current study was similar to Stadler . Furthermore, we used the questionnaire to compare groups.…”

Section: Discussionmentioning

confidence: 99%

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Bos

Antonescu

Osinga

et al. 2018

Pediatric Dermatology

View full text Add to dashboard Cite

Background Adherence to topical corticosteroids is low among atopic dermatitis patients and their parents. This can lead to treatment failure and decreased quality of life. Objective To assess and compare the worries and beliefs concerning topical corticosteroids among parents of children with atopic dermatitis, involved health care professionals, and between different professionals. Also, we identify factors associated with corticosteroid phobia (corticophobia) in professionals. Methods Parents and health care professionals were invited to complete a questionnaire about corticophobia (Topicop). Higher questionnaire scores, expressed as a percentage, indicate more severe corticophobia. Professionals were asked to answer the questions as though they were using topical corticosteroids on their own child. Results The scores for 29 parents and 31 public health care nurses were equal: 44%. The score for 51 general practitioners was 39%. The score for 33 public health care physicians and of 47 pediatricians was 31%. The differences between parents and these professionals were statistically significantly different (P = 0.001). Type of profession and having a child with atopic dermatitis were significantly associated factors for the score. Conclusion Corticophobia is present among parents of children with atopic dermatitis and among health care professionals involved in caring for children with atopic dermatitis. Health care nurses express the same level of corticophobia as parents. The presence of corticophobia among health care professionals may affect parental perspectives and topical corticosteroids adherence negatively.

show abstract

Section: Discussionmentioning

confidence: 99%

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Bos

Antonescu

Osinga

et al. 2018

Pediatric Dermatology

View full text Add to dashboard Cite

show abstract

“…For example, in Taiwan, the effectiveness of wet‐wrap therapy may be limited because of the humid climate of the country . Treatment in Taiwan and other countries may also be influenced by steroid phobia among patients . In India, it is suggested that in warmer months, patients be kept cool using air conditioning or fans (when air conditioning is not feasible).…”

Section: Managementmentioning

confidence: 99%

“…46 Treatment in Taiwan and other countries may also be influenced by steroid phobia among patients. 52 In India, it is suggested that in warmer months, patients be kept cool using air conditioning or fans (when air conditioning is not feasible). It is also suggested that ear piercing be delayed in children until they are at least 8 years old.…”

Section: Managementmentioning

confidence: 99%

Burden of atopic dermatitis in Asia

Tsai

Rajagopalan

Chu

et al. 2019

The Journal of Dermatology

View full text Add to dashboard Cite

Atopic dermatitis is a chronic, inflammatory skin disease characterized by intense pruritus and eczematous lesions. It is considered one of the most common chronic conditions, with an estimated global prevalence of nearly 230 million. As in the rest of the world, prevalence of atopic dermatitis has been increasing in Asian countries over the last few decades. This increased prevalence in Asian countries has been attributed to factors such as rapid urbanization, increasingly Westernized lifestyles, and improved standards of living and education. As a result, it is important to understand the increasing burden of disease in Asian countries and the differences between the countries in terms of epidemiology, diagnostic criteria, management, quality of life and economic burden.

show abstract

“…The TOPICOP is able to assess various degrees of steroid anxiety in routine clinical practice. We translated the scale into Japanese and reported the feasibility in 2015, and Stalder et al reported feasibility in 2017 based on an international feasibility study of TOPICOP conducted in 15 countries including Japan . The current study was additional analysis by using a part of Japanese data of the feasibility study.…”

Section: Introductionmentioning

confidence: 99%

Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross‐sectional study using TOPICOP in Japan

Saito‐Abe

Futamura

Yamamoto‐Hanada

et al. 2019

Pediatric Dermatology

View full text Add to dashboard Cite

All the authors have approved the manuscript and agree with submission to Pediatric Dermatology.This study was carried out with the approval of the hospital ethics committee of the National Center for Child Health and Development (Reception number: 761). AbstractBackground/Objectives: The TOPICOP scale is an easy-to-use scale for assessing topical corticosteroid (TCS) phobia in atopic dermatitis (AD) patients and their caretakers. TCS phobia is a common problem among AD patients and their caretakers.The aim of this study was to examine the relationship between TCS phobia in caretakers of children with AD and the characteristics of patients using the TOPICOP scale. Methods: Caretakers of AD patients who visited the allergy clinic at the National Center for Child Health and Development in Tokyo between February 2014 and May 2014 were recruited. Caretakers of patients in follow-up had already attended an education session on treatment at the institution. All participants completed an anonymous questionnaire on the characteristics of the respondents and patients using the Patient-Oriented Eczema Measure (POEM) and the Japanese version of TOPICOP.Results: In total, 243 participants (88.9% female) completed the survey. The average TOPICOP score was 40.3 and the median POEM score was 4. The TOPICOP score was significantly higher for patients younger than 12 months old with moderate to very severe AD (POEM ≥ 8) whose caretaker had not attended an educational session (P < 0.01, respectively). There was no significant difference in the family history of AD, age, or gender of the respondents. In multivariable analysis, preattendance at an education session was the only significant factor accounting for a higher TOPICOP score (P < 0.001). Conclusions:Regardless of their background, caretakers of AD patients can be affected from TCS phobia. Attending an educational session might ease their anxiety. K E Y W O R D S atopic dermatitis, questionnaire, steroid phobia, topical corticosteroid, TOPICOP 312 | Pediatric Dermatology SAITO-ABE ET Al. Patients Age, median (range) 238 4 (range: 0-17) POEM, median (range) 243 4 (2-9) Very severe (25-28), n (%) 2 (0.8) Severe (17-24), n (%) 17 (7.0) Moderate (8-16), n (%) 60 (24.7) Mild (3-7), n (%) 72 (29.6) Clear or almost clear (0-2), n (%) 92 (37.9) AD class attendance: Preattendance, n (%) 237 95(40.1) Family history of AD, n (%) 243 143 (58.8) Mother history, n (%) 243 74 (30.5) Father history, n (%) 243 77 (31.7) Sibling history, n (%) 243 50 (20.6) a Number of respondents and patients without missing value.

show abstract

Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score

Abstract: The TOPICOP score can be feasibly applied across countries and may therefore be useful for obtaining qualitative and quantitative data from international studies and for adapting patient education and treatment.

Cited by 65 publications

References 19 publications

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Burden of atopic dermatitis in Asia

Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross‐sectional study using TOPICOP in Japan

Contact Info

Product

Resources

About